Nasopharyngeal carcinoma (NPC) is a unique head and neck cancer, where the endemic subtype is strongly associated with Epstein-Barr virus (EBV) infection, whereas emerging data suggest that a subset ...
Throat cancer remains one of the most challenging yet increasingly treatable forms of cancer affecting thousands of Americans each year. This complex disease impacts the pharynx (throat) or larynx ...
Penpulimab-kcqx is approved for first-line treatment of recurrent or metastatic non-keratinizing NPC in combination with cisplatin or carboplatin and gemcitabine. As a single agent, penpulimab-kcqx is ...